My wife says that at the rate I’m going, we’re going to have to buy a new table.

Let me explain. My job as your tech analyst is to go beyond the headlines and find great tech stocks that can absolutely crush the market – in good times and in bad.

And that often means pounding the table for the global tech ecosystem in general, and for market rippers in particular.

That’s exactly what I did back on Jan. 11. You may not recall it, but in my mind’s eye, it’s as if it were just yesterday.

At the time, the tech-centric Nasdaq had entered bear market territory, defined as a 20% drop from a recent high. I said it was “fear and not fundamentals” that was driving the market lower.

I then listed three beaten-down tech leaders I said were poised for big rebounds.

Today, I’m following up let you know – all three just crushed it, as I’ll show you. And I’ll also show you why there’s still plenty of upside ahead…

With apologies to Yogi Berra, it’s like deja vu all over again.

During that Jan. 11 chat, I noted the Nasdaq was far from alone in the selloff. Stocks were broadly and brutally battered with the S&P 500 off 19%.

We’re in a similar situation today. Stocks are getting broadly battered on fears about rising trade tensions with China after President Trump said he’d put tariffs on $300 billion of additional Chinese goods.

But now as then, I pointed out that the economy was in overall great shape, as evidenced by the best jobs market in nearly 50 years.

So, I have no doubt about my mantra – the road to wealth is paved with tech. Here is what I said at the time:

“I believe that tech will once again lead the market higher as it has done since the bull market began nearly 10 years ago. And that means we will have plenty of chances to make money on tech shares in the year ahead.”

And to make sure you had actionable intelligence, I listed three beaten-down tech leaders poised for a massive rebound. I’m happy to report that all three have had a great year.

Now then, to be consistent, I’m going to mark their rallies from Dec. 24, when the market rebounded. I’ve been using that date all year, and I think it’s important to remain consistent. Take a look at these three market crushers.

Oversold Tech Leader No. 1: Adobe Inc. (ADBE)

Even in the best of bull markets, a gain of 36.6% in just over seven months is nothing to sneeze at. That means Adobe beat the broad market by 72.6% in the period.

Then again, Adobe said on June 18 that it had achieved record quarterly revenue of $2.74 billion for its fiscal second quarter ended May 31. Those sales were up 25% from the year-ago quarter.

With earnings of $1.83 a share, it beat forecasts. It also offered an upbeat report for the rest of the year. Following that bullish report, no fewer than 11 analysts upgraded the stock.

I have to say that I’m not surprised at how well this software leader is really doing. I’ve recommended this stock several times since the summer of 2013.

I’ve done so because the company has done a great job of moving from standard software sales to recurring revenue through a cloud-delivery format.

It now offers a suite of products through its Creative Cloud platform that is nothing short of a cash machine. It has profit margins of 39%, and a 38% return on equity.

The firm also has a crackerjack CEO. Barrons named Shantanu Narayen one of the world’s best CEOs in 2016 and 2017. I’m projecting 35% gains over the next three years.

Oversold Tech Leader No. 2: Square Inc. (SQ)

I have to say that Square once again defied the skeptics with a return of 27.9% since Dec. 24. That was enough to beat the broader market by 31.6%.

Irony abounds. This is one of those stocks where Wall Street periodically hits the panic button – giving savvy tech investors new entry points at a discount from its long term upside.

That happened again on Aug. 2, when the Street freaked out over the fintech leader’s second-quarter financials. It beat on sales and earnings, but the stock got hammered.

Turns out Square guided a little lighter for the third quarter than what analysts had forecast. But their loss is your gain.

Square is making a series of bold moves to improve growth and strengthen earnings, moves that will bolster the stock over the long run.

For instance, the firm is selling its Caviar food-delivery unit for $400 million. That means it is exiting a tough business with low margins to invest in products that make it a stronger fintech leader.

Now, it has plenty of money to invest in online shopping business and CashApp, which competes with Venmo, a unit of PayPal Holdings Inc. (PYPL).

In other words, CEO and founder Jack Dorsey just keeps on defying the skeptics. He’s become the king of upsell by adding new products and features that improves service for clients and earnings for the firm. I’m projecting 3-year gains of 50%.

Oversold Tech Leader No. 3: HealthEquity Inc. (HQY)

I believe the nearly 39.6% gain for HealthEquity is nothing short of amazing. Yes, it beat the market by nearly 87%.

But that’s not the main thing. See, the stock has done well, despite the politics of healthcare.

It seems that every election cycle, politicians want to bang on health insurers. This time, several 2020 Democratic presidential hopefuls have called for the end of private health insurance as we know it.

So, against that backdrop, the firm is really defying the odds.

But the fears mask a key fact: HealthEquity is riding a massive trend of health savings accounts (HSAs). These are wildly popular with the public because they provide patients far more choice in their health-spending decisions.

HealthEquity manages 4.8 million HSAs and $9.7 billion in assets. Over the past three years, HealthEquity has grown its earnings per share by an average 49%, which means they are doubling every 18 months.

And it’s just bulked up for another round of growth. The company recently paid $2 billion to acquire WageWorks. The deal unites two of the nation’s largest HSA firms.

HQY now has 115,000 employer clients, including two-thirds of Fortune 500 firms. I’m projecting 3-year gains of 45%.

Add it all up and you can see it pays to ignore all the market noise out there. In fact, that’s exactly what we do here at Strategic Tech Investor – and that’s why we keep serving you a steady stream of market crushers.

Let me close with a quotation from my Jan. 11 column:

“I believe that when we close the books on 2019, we’ll look back and see that these beaten-down leaders offered great opportunities to build your net worth.”

Now, when it comes to the latest trends in healthcare, I want to let you know about another opportunity before I go.

See, a tiny biotech firm has developed a radical new technology that’s already being used by the U.S. military and trauma and cancer treatment centers around the world.

And this firm holds the key to developing this technology that has the potential to save over two million peoples’ lives. Not only that, but production of this product is expected to be made standard throughout some of the largest blood-processing sites across the United States.

This could easily lead to triple-digit gains for folks who get in early.